Akèy › Kansè fwa (Kasinòm epatoselilè) › New Jersey
Etid klinik pou Kansè fwa (Kasinòm epatoselilè) nan New Jersey
10 etid pou Kansè fwa (Kasinòm epatoselilè) ap chèche patisipan nan sit nan New Jersey.
Vil nan New Jersey
Tèks ofisyèl etid la (Anglè)
A Study of ZW251 in Participants With Advanced Solid Tumors
- Hackensack University Medical Center, Hackensack
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 5, 2026 · NCT07164313Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
- Exelixis Clinical Site #88, East Brunswick
- Exelixis Clinical Site #105, Hackensack
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT05176483A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT07291076Evaluating Novel Therapies in ctDNA Positive GI Cancers
- John Theurer Cancer Center at Hackensack University Medical Center, Hackensack
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 14, 2026 · NCT05482516Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, New Brunswick
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Sep 3, 2026 · NCT06921785First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
- Research Site, Hackensack
Ap rekriteFaz 1/2
Laj 18 ak plis · Tout sèks · Mizajou Aug 13, 2026 · NCT06795022A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Overlook Medical Center, Summit
Ap rekriteFaz 2
Laj 8 ak plis · Tout sèks · Mizajou Jul 27, 2026 · NCT05503797Tislelizumab Consolidation After Liver-Directed Therapy for Hepatocellular Carcinoma
- Rutgers Cancer Institute of New Jersey, New Brunswick
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Jan 20, 2026 · NCT05366829SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, New Brunswick
Ap rekriteEtid obsèvasyon
Tout laj · Tout sèks · Mizajou Oct 28, 2025 · NCT03452774Novel Method to Assess Hepatic Regeneration and Predict Hepatic Related Morbidity After Partial Hepatectomy
- Englewood Hospital, Englewood
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2025 · NCT06681818Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.